Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion type Assertion NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_head.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion description "[These results suggest that FOXA2 induces the differentiation of gastric cancer and highlight FOXA2 as a novel therapeutic target and prognostic marker for human gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_provenance.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion evidence source_evidence_literature NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_provenance.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion SIO_000772 25129104 NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_provenance.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion wasDerivedFrom befree-2016 NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_provenance.
- NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_assertion wasGeneratedBy ECO_0000203 NP1211250.RAqve9oQ-JmYG6c4uE8rvfb5_OLju_7xIWLdrojS74VLo130_provenance.